Australia markets open in 4 hours 56 minutes

Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.7609-0.1591 (-17.29%)
At close: 04:00PM EDT
0.7581 -0.00 (-0.37%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.68B
Enterprise value 1.08B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.17
Price/book (mrq)1.70
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.42
52-week change 3-42.35%
S&P500 52-week change 326.27%
52-week high 32.5450
52-week low 30.7200
50-day moving average 31.0324
200-day moving average 31.4685

Share statistics

Avg vol (3-month) 333.74M
Avg vol (10-day) 364.14M
Shares outstanding 51.71B
Implied shares outstanding 62.21B
Float 81.32B
% held by insiders 16.52%
% held by institutions 179.60%
Shares short (30 Apr 2024) 4289.73M
Short ratio (30 Apr 2024) 47.55
Short % of float (30 Apr 2024) 423.68%
Short % of shares outstanding (30 Apr 2024) 413.15%
Shares short (prior month 28 Mar 2024) 4270.83M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-469.12%

Management effectiveness

Return on assets (ttm)-21.76%
Return on equity (ttm)-65.81%

Income statement

Revenue (ttm)208.7M
Revenue per share (ttm)0.11
Quarterly revenue growth (yoy)-53.00%
Gross profit (ttm)N/A
EBITDA -630.63M
Net income avi to common (ttm)-853.81M
Diluted EPS (ttm)-0.4300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)840.44M
Total cash per share (mrq)0.38
Total debt (mrq)234.5M
Total debt/equity (mrq)23.75%
Current ratio (mrq)5.34
Book value per share (mrq)0.46

Cash flow statement

Operating cash flow (ttm)-294.17M
Levered free cash flow (ttm)-159.04M